News

ISB and Seattle Science Foundation Partner to Create Video Series

What are multi-omics? Why does our microbiome matter? What’s the difference between genetics and genomics? What is a digital twin? ISB and Seattle Science Foundation have partnered to create videos answering questions like these and more, showcasing ISB scientists and their work.

Predicting ‘Long COVID’ At Initial Point of COVID-19 Diagnosis

Researchers have identified several factors that can be measured at the initial point of COVID-19 diagnosis that anticipate if a patient is likely to develop long COVID. They also found that mild cases of COVID-19, not just severe cases, are associated with long COVID. Their findings were published by the journal Cell.

Tackling Lyme Disease with Immunity

It’s Lyme disease season in many areas of the United States, including the Northeast, the Midwest, and some places on the West Coast. In our latest Research Roundtable event, ISB Associate Professor Dr. Naeha Subramanian discussed the latest Lyme disease research conducted in her lab.

Dr. Naeha Subramanian

Dr. Naeha Subramanian Promoted to Associate Professor

Dr. Naeha Subramanian – an expert in immunology, innate immunity, and host-pathogen interactions, and head of ISB’s Subramanian Lab – has been promoted to Associate Professor. “I am honored with this promotion and excited about the incredible research being conducted in my lab. It is a pleasure and privilege to tackle exciting questions everyday,” she said.

Drs. Naeha Subramanian, Leah Rommereim Gilmore, and Ajay Suresh Akhade

Small, Persistent Increase in the Expression of NOD1 May Promote Cancer Risk

ISB researchers have found that a small, persistent increase in the expression of NOD1 could be responsible for higher cancer risks. The research team found that a slight 1.5-fold uptick in NOD1 expression can activate the protein and downstream signaling pathways in a manner similar to vast (30- to 200-fold) overexpression. 

Dr. Jim Heath at ISB

Inside the intense world of COVID-19 science, and unexpected findings from Seattle researchers

GeekWire published a story spotlighting ISB’s COVID-19 research. Reporter Lisa Stiffler spoke with ISB President Dr. Jim Heath about the breakneck pace ISB and all of our collaborative partners are working at to tease out COVID’s biological secrets to advance the understanding and treatment of the novel coronavirus.

Subramanian and Akhade

How Salmonella Co-Opts the Host Immune System to Conceal Itself

While scientists have long studied bacterial infections, less attention has been paid to how the host immune response affects bacterial gene expression in the body. In a just-published paper in PNAS, ISB researchers detailed how the bacterium Salmonella conceals itself from the host immune system.

Dr. Subramanian Presents at Cytokines 2020

ISB Assistant Professor Dr. Naeha Subramanian presented at the virtual meeting, Cytokines 2020, on November 1-4. Talk are available on demand for the registrants until November 18.

Illustration of a person using a katana to slash a coronavirus in half

COVID-19 Immune Response Study Could Lead to More Effective Treatments

Findings from the ISB-Swedish COVID-19 Immune Response Study suggest that treatments aimed at arresting the infection at the stage of moderate severity may be most effective. The team studied 139 patients and found that mild COVID-19 is very distinct from the moderate or severe forms of disease, which appear surprisingly similar. 

Ajay receives AAI Trainee Abstract Award

Subramanian Lab Research Scientist Dr. Ajay Akhade receives AAI Trainee Abstract Award. His abstract was selected for an oral presentation. The American Association of Immunologists is an association of professionally trained scientists from all over the world dedicated to advancing the knowledge of immunology and its related disciplines.

Sreetama Choudhury awarded an AAI Career Reentry Fellowship

The AAI Fellowship Program for Career Reentry provides support for immunologists to reenter the workforce after a lapse of research or research training due to medical leave or family circumstances.

‘ENDING LYME:’ JUST-RELEASED VIDEO HIGHLIGHTS ISB’S NOVEL LYME DISEASE RESEARCH

Since national surveillance of Lyme Disease started in 1982, the number of cases reported annually has increased nearly 25-fold. Lyme Disease specialist Dr. Susan Marra recently produced a video, “Ending Lyme,” about the latest in Lyme research that features ISB Drs. Jim Heath, Lee Hood, Rob Moritz, Naeha Subramanian and Nathan Price.

Cliff Rostomily awarded a Global Lyme Alliance Research Fellowship for 2019-2020

Leah and Ajay Receive AAI Trainee Abstract Awards

Leah and Ajay receive AAI Trainee Abstract Awards. Their abstracts are selected for oral presentations at Immunology 2019

Postdoc Appreciation 2017

Postdoc Appreciation 2017

In honor of National Postdoc Appreciation Week in late September, ISB’s staff recently gathered to honor and celebrate all of our devoted and hardworking postdocs. The event included speeches from a number of faculty members. “Postdocs are the heart of ISB,” Dr. Nathan Price, professor and associate director, told the gathering.

2017 ISB Intern Akanksha Bawa

2017 Undergrad Intern Showcase

Summer 2017 brought a fresh cohort of undergraduate students interested in exploring ISB’s research in the Summer Undergraduate Research Experience Program.

Systems Biology Opens the Blackest Boxes

Few systems approach the complexity of our own immune system, which promotes a swift and powerful host defense by coordinating a dynamic, multiscale set of hierarchically organized molecular, cellular, and organismal components. This article in Genetic Engineering and Biotechnology News covered Dr. Subramanian’s presentation at the symposium, “Future of Health.”

Wilke Cohen Lyme Disease Project Receives $3M from the Steven & Alexandra Cohen Foundation

PRESS RELEASE Total Funding Has Reached $6.1 Million ISB Researchers Have Discovered Potential Biomarkers and Successfully Reproduced the Borrelia Bacteria in the Lab SEATTLE – June 1, 2016 – Institute for Systems Biology (ISB) has received a transformational, multi-year pledge from the Steven & Alexandra Cohen Foundation to support the Wilke Cohen Lyme Disease Project. In addition to an initial $3.1 million in funding from Jeff and Liesl Wilke, Jeff…